Cargando…
Considerations in Understanding Vaccine Effectiveness
Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the p...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864852/ https://www.ncbi.nlm.nih.gov/pubmed/36679865 http://dx.doi.org/10.3390/vaccines11010020 |
_version_ | 1784875687698497536 |
---|---|
author | Lau, Chin Shern Aw, Tar Choon |
author_facet | Lau, Chin Shern Aw, Tar Choon |
author_sort | Lau, Chin Shern |
collection | PubMed |
description | Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the population. Disease prevalence significantly impacts absolute risk reduction and could skew expected efficacy when increased disease prevalence inflates the absolute risk reduction in the face of a constant relative risk reduction. These factors must be considered in the interpretation of vaccine effectiveness to better understand how vaccines can improve disease prevention among the population. We highlight the impact of various factors on vaccine effectiveness. |
format | Online Article Text |
id | pubmed-9864852 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98648522023-01-22 Considerations in Understanding Vaccine Effectiveness Lau, Chin Shern Aw, Tar Choon Vaccines (Basel) Commentary Although vaccine effectiveness reports are essential to assessing policies on SARS-CoV-2 vaccination, several factors can affect our interpretation of the results. These include the waning of antibodies, the prevailing viral variants at the time of the study, and COVID-19 disease prevalence in the population. Disease prevalence significantly impacts absolute risk reduction and could skew expected efficacy when increased disease prevalence inflates the absolute risk reduction in the face of a constant relative risk reduction. These factors must be considered in the interpretation of vaccine effectiveness to better understand how vaccines can improve disease prevention among the population. We highlight the impact of various factors on vaccine effectiveness. MDPI 2022-12-22 /pmc/articles/PMC9864852/ /pubmed/36679865 http://dx.doi.org/10.3390/vaccines11010020 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Commentary Lau, Chin Shern Aw, Tar Choon Considerations in Understanding Vaccine Effectiveness |
title | Considerations in Understanding Vaccine Effectiveness |
title_full | Considerations in Understanding Vaccine Effectiveness |
title_fullStr | Considerations in Understanding Vaccine Effectiveness |
title_full_unstemmed | Considerations in Understanding Vaccine Effectiveness |
title_short | Considerations in Understanding Vaccine Effectiveness |
title_sort | considerations in understanding vaccine effectiveness |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864852/ https://www.ncbi.nlm.nih.gov/pubmed/36679865 http://dx.doi.org/10.3390/vaccines11010020 |
work_keys_str_mv | AT lauchinshern considerationsinunderstandingvaccineeffectiveness AT awtarchoon considerationsinunderstandingvaccineeffectiveness |